{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:58:38Z","timestamp":1774141118065,"version":"3.50.1"},"reference-count":43,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,4,13]],"date-time":"2009-04-13T00:00:00Z","timestamp":1239580800000},"content-version":"vor","delay-in-days":102,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Clinical Apheresis"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transfusion\u2010related lung injury (TRALI) occurs in \u223c1 in 5,000 transfusions and may cause considerably more morbidity and mortality that is not recognized in clinical practice. Based on the current understanding of the etiology of TRALI, blood centers have implemented or are evaluating various donor and component management strategies in an effort to mitigate the risk of TRALI. Many cases of TRALI are likely caused by antibodies to leukocyte antigens (HLA or HNA) in blood components. Approximately 10 to 20% of female blood donors with a history of pregnancy and 1 to 5% of male blood donors harbor these antibodies. Alternatively, TRALI may be mediated by other bioactive lipids or substances that accumulate during storage and cause a reaction when transfused to susceptible patients. The complex interplay among various donor\u2010, component\u2010, and patient\u2010related factors underlying TRALI guarantees that effective prevention will not be a single or simple intervention but rather will require a multifaceted approach. Perhaps, the most important risk reduction strategy is the effort to ensure appropriate use of blood products and eliminate unnecessary transfusions. Blood collection agencies, however, have more proximate control over donor selection and component management than transfusion practice. AABB has provided some guidance on deferring donors implicated in TRALI and minimizing the preparation of high plasma volume components from donors who have anti\u2010leukocyte antibodies or are at increased risk of leukocyte alloimmunization. Blood centers have taken various approaches to mitigate the risk of TRALI, and the possible benefit and the inherent limitations of the current strategies will be reviewed. J. Clin. Apheresis 2009. \u00a9 2009 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jca.20198","type":"journal-article","created":{"date-parts":[[2009,4,13]],"date-time":"2009-04-13T15:16:54Z","timestamp":1239635814000},"page":"122-129","source":"Crossref","is-referenced-by-count":31,"title":["TRALI risk reduction: Donor and component management strategies"],"prefix":"10.1002","volume":"24","author":[{"given":"Anne F.","family":"Eder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,13]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04347.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00956.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000159849.94750.51"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00193.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2929"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000214292.62276.8E"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1985.25686071434.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.497"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2005.00648.x"},{"key":"e_1_2_1_11_2","unstructured":"AABB.Standards for Blood Banks and Transfusion Services 24th ed. AABB Standard 5.4.21.Bethesda MD:AABB;2006."},{"key":"e_1_2_1_12_2","volume-title":"Transfusion Related Acute Lung Injury, AABB Bulletin #05\u201006","author":"AABB","year":"2005"},{"key":"e_1_2_1_13_2","volume-title":"Transfusion Related Acute Lung Injury, AABB Bulletin #06\u201007","author":"AABB","year":"2006"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2006.00870.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01403.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01321.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01102.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41101244.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00374.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00285.x"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27238"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000214287.58444.2D"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00930.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.04053.x"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.15.1968"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.315"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.01148.x"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0958-7578.2004.00504.x"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0041-1132.2004.04193.x"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.2002.00401_1.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2007.00920.x"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39199116901.x"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01184.x"},{"key":"e_1_2_1_34_2","first-page":"P4","article-title":"Relationship of HLA antibodies in blood donors to pregnancy and transfusion history","volume":"47","author":"Triulzi D","year":"2007","journal-title":"Transfusion"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01457.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(03)00039-7"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2007.05.003"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1309\/KNTUCTNAGL5W7R1R"},{"key":"e_1_2_1_39_2","unstructured":"Serious Hazards of Transfusion Steering Group Serious Hazards of Transfusion (SHOT) Annual Report 2004. Available athttp:\/\/www.shotuk.org\/SHOT%20REPORT%202004.pdf. Accessed on July 4th 2006."},{"key":"e_1_2_1_40_2","unstructured":"SebokMA BenjaminRJ EderAF.Trends in the Utilization of Plasma Frozen Within 24 hours and Fresh Frozen Plasma AABB Annual Meeting. Anaheim CA: AABB;2007."},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.21307\/immunohematology-2019-333","article-title":"Plasma Components","volume":"23","author":"Eder AF","year":"2007","journal-title":"Immunohematology"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41020264.x"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1159\/000190309"},{"key":"e_1_2_1_44_2","volume-title":"Interpreting the Precautionary Principle","author":"O'Riordan T","year":"1994"}],"container-title":["Journal of Clinical Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjca.20198","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jca.20198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T19:44:45Z","timestamp":1699904685000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.20198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1002\/jca.20198"],"URL":"https:\/\/doi.org\/10.1002\/jca.20198","archive":["Portico"],"relation":{},"ISSN":["0733-2459","1098-1101"],"issn-type":[{"value":"0733-2459","type":"print"},{"value":"1098-1101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}